Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403305
Max Phase: Preclinical
Molecular Formula: C35H58N6O7
Molecular Weight: 674.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3403305
Max Phase: Preclinical
Molecular Formula: C35H58N6O7
Molecular Weight: 674.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C
Standard InChI: InChI=1S/C35H58N6O7/c1-10-41(11-2)34(46)28(19-25-15-13-12-14-16-25)39-32(44)27(17-21(3)4)38-33(45)30(23(7)8)40-31(43)26(36)20-48-35(47)29(18-22(5)6)37-24(9)42/h12-16,21-23,26-30H,10-11,17-20,36H2,1-9H3,(H,37,42)(H,38,45)(H,39,44)(H,40,43)/t26-,27-,28-,29-,30-/m0/s1
Standard InChI Key: FSYVJQSCASNVCA-IIZANFQQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 674.88 | Molecular Weight (Monoisotopic): 674.4367 | AlogP: 1.68 | #Rotatable Bonds: 20 |
Polar Surface Area: 189.03 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.83 | CX Basic pKa: 7.22 | CX LogP: 2.08 | CX LogD: 1.86 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.13 | Np Likeness Score: -0.18 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):